Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 804 results for "daiichi sankyo company"

Amgen and Daiichi Sankyo make deal for biosimilars in Japan

US-based biologicals specialist Amgen and Japan-based Daiichi Sankyo announced on 13 July 2016 that they had made an exclusive agreement to commercialize nine biosimilars in Japan. The deal includes several biosimilars in late-stage ... GaBi Online, 3 weeks ago

10 images for daiichi sankyo company

Nasdaq, 1 month ago
Nasdaq, 1 month ago
Reuters India, 2 months ago
Business Insider, 2 months ago
Reuters India, 3 months ago
Channel NewsAsia, 2 months ago
Yahoo! India, 3 months ago
Yahoo! India, 3 months ago
Stock Nod, 5 months ago, 3 months ago

Edited Transcript of 4568.T earnings conference call or presentation 29-Jul-16 10:59am GMT

Q1 2017 Daiichi Sankyo Co Ltd Earnings Call Tokyo Aug 2, 2016 (Thomson StreetEvents) -- Edited Transcript of Daiichi Sankyo Co Ltd earnings conference call or presentation Friday, July 29, 2016 at 10:59:00am GMT TEXT version of Transcript ...
 Yahoo! Finance4 weeks ago DAIICHI SANKYO : Researchers at Daiichi Sankyo Release New Data on Immunoglobulins (Suppression of Methionine Oxidation of a Pharmaceutical Antibody Stored in a...  4 Traders1 month ago UCB's Vimpat Approved in Japan for Partial Onset Seizures  Yahoo! Singapore1 month ago Japanese MHLW approves lacosamide as adjunctive therapy to treat partial-onset seizures in patients with epilepsy  PharmaBiz1 month ago

Amgen, Daiichi Sankyo team up for biosimilars in Japan

Amgenis on the cusp of getting its first biosimilar approved in the U.S., a knockoff of arthritis fighter Humira, having this week won unanimous support from an FDA advisory committee. When it comes time to take the drug to Japan, the drugmaker will ...
 FiercePharma1 month ago Amgen partners with Daiichi on biosimilars after positive FDA panel  FierceBiotech1 month ago Amgen and Daiichi Sankyo Team Up for Biosimilars in Japan  Yahoo! Finance1 month ago Approval of Novartis Biosimilar: Causing Battle of Amgen, AbbVie and Pfizer in Biosimilar Market  CPhI.cn1 month ago

Hold Daiichi for contempt of court responsible for leak: RH Holdings

MUMBAI: RH Holdings, the firm owned by former Ranbaxy promoter Malvinder Singh, has said the Diiachi Sankyo should be held for contempt of court for leaking the confidential documents of the Singapore Tribunal Board (STB). The company's statement ...
 Economic Times2 weeks ago

BRIEF-Daiichi Sankyo plans 5th&6th series unsecured corporate bonds worth total 100 bln yen

July 15 Daiichi Sankyo Co Ltd : * Says it plans to issue 5th series unsecured corporate bonds worth 75 billion yen, with coupon rate of 0.810 percent and maturity date on July 25, 2036 * Says it plans to issue 6th series unsecured corporate ...
 Reuters UK1 month ago BRIEF-Daiichi Sankyo plans 28 mln shares repurchase  Reuters UK2 months ago BRIEF-Daiichi Sankyo to buy back up to 50 bln yen of stock  Reuters UK2 months ago

UCB, Daiichi Sankyo receive Japanese approval for additional indication of lacosamide

Singapore: Daiichi Sankyo Company Limited and Brussels' UCB Biopharma SPRL has announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has granted approval for lacosamide (brand name VIMPAT) as an adjunctive therapy in the treatment ...
 Bio Spectrum Asia1 month ago Regeneron-Sanofi's Praluent gets Japan MHLW nod  FiercePharma1 month ago

UCB scores Japanese approval for seizure therapy, Vimpat

UCB Biopharma (EURONEXT: UCB) and Daiichi Sankyo have announced that Vimpat (lacosamide) has been approved as an adjunctive therapy in the treatment of partial onset seizures in adult patients with epilepsy in Japan. Vimpat is approved in this ...
 Pharmafile1 month ago BRIEF-UCBs Vimpat gets Japanese approval  Reuters UK1 month ago

Ranbaxy Laboratories Owners Deliberately Buried Information From Daiichi Sankyo: Singapore Tribunal Order

August 11, 2016 By Alex Keown , Breaking News Staff MUMBAI, India More sour news has surfaced from the Daiichi Sankyo acquisition of Ranbaxy Labs ( RANBAXY.BO ) as new details emerged of the Ranbaxy owners deliberately ...
 Pharma Live2 weeks ago

New and Generic Drug Approvals: Welchol

Drug Name(s) WELCHOL FDA Application No. (NDA) 021176 Active Ingredient(s) COLESEVELAM HYDROCHLORIDE Company DAIICHI SANKYO Original Approval or Tentative Approval Date May 26, 2000 Chemical Type 1New molecular entity (NME) Review ...
 U.S. Food and Drug Administration1 month ago

DAIICHI SANKYO : Announces Details of Executive Share Options

Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, Representative Director, President and CEO (Code no.: 4568, First Section, Tokyo Stock Exchange) Please address inquiries to Noriaki Ishida, Executive Officer, Vice ...
 4 Traders1 month ago DAIICHI SANKYO : Japan Research Foundation for Clinical Pharmacology 9th Annual Clinical Pharmacology Research Award  4 Traders2 months ago DAIICHI SANKYO : to Issue Share Options as Remuneration  4 Traders2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - daiichi sankyo company
Get updated on latest news & your favorite topics right in your inbox!
More     Less